Antimicrobial activity of curcumin against helicobacter pylori isolates from India and during infections in mice

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1592-1597

  De, Ronita ^a   Kundu, Parag ^b   Swarnakar, Snehasikta ^b   Ramamurthy, T ^a   Chowdhury, Abhijit ^c   Nair, G Balakrish ^a   Mukhopadhyay, Asish K ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; SHIKIMIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; GENE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOMACH INJURY;

ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CURCUMIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; STOMACH;

EID: 65649144787     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01242-08     Document Type: Article

References (32)

1. Alarcón, T., D. Domingo, and M. López-Brea. 1999. Antibiotic resistance problems with Helicobacter pylori. Int. J. Antimicrob. Agents 12:19-26. (Pubitemid 29241820)
2. Apisariyakul, A., N. Vanittanakom, and D. Buddhasukh. 1995. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J. Ethnopharmacol. 49:163-169. (Pubitemid 26020115)
3. Broutet, N., S. Tchamgoué, E. Pereira, H. Lamouliatte, R. Salamon, and F. Megraud. 2003. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment. Pharmacol. Ther. 17:99-109. (Pubitemid 36140439)
4. Chattopadhyay, S., R Patra, T. Ramamurthy, A. Chowdhury, A. Santra, G. K. Dhali, S. K Bhattacharya, D. E. Berg, G. B. Nair, and A. K. Mukho-padhyay. 2004. Multiplex PCR assay for rapid detection and genotyping of Helicobacter pylori directly from biopsy specimens. J. Clin. Microbiol. 42: 2821-2824. (Pubitemid 38750217)
5. Coggins, J. R, C. Abell, L. B. Evans, M. Frederickson, D. A. Robinson, A. W. Roszak, and A. P. Lapthorn. 2003. Experiences with the shikimate-pathway enzymes as targets for rational drug design. Biochem. Soc. Trans. 31:548-552. (Pubitemid 36750729)
6. Covacci, A., J. L. Telford, G. D. Giudice, J. Parsonnet, and R. Rappuoli. 1999. Helicobacter pylori virulence and genetic geography. Science 284:1328-1333. (Pubitemid 29289653)
7. Datta, S., S. Chattopadhyay, R Patra, R. De, T. Ramamurthy, J. Hembram, A. Chowdhury, S. K. Bhattacharya, D. E. Berg, G. B. Nair, and A. K. Mukhopadhyay. 2005. Most Helicobacterpylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment. Pharmacol. Ther. 22:51-57. (Pubitemid 40943875)
8. Di Mario, F., L. G. Cavallaro, A. Nouvenne, N. Stefani, G. M. Cavestro, V. Iori, M. Maino, G. Comparato, L. Fanigliulo, E. Morana, A. Pilotto, L. Martelli, M. Martelli, G. Leandro, and A. Franzè. 2007. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: some-thing to learn from failure? Helicobacter 12:238-243. (Pubitemid 46701091)
9. Goel, A., A. B. Kunnumakkara, and B. B. Aggarwal. 2008. Curcumin as "curecumin": from kitchen to clinic. Biochem. Pharmacol. 75:787-809.
10. Graham, D. Y. 1998. Antibiotic resistance in Helicobacter pylori: implication for therapy. Gastroenterology 115:1272-1277. (Pubitemid 28485620)
11. Han, C, L. Wang, K. Yu, L. Chen, L. Hu, K, Chen, H. Jiang, and X. Shen. 2006. Biochemical characterization and inhibitor discoveiy of shikimate dehydrogenase from Helicobacter pylori. FEBS J. 273:4682-4692. (Pubitemid 44506909)
12. Han, S. S., S. T. Chung, D. A. Robertson, D. Ranjan, and S. Bondada. 1999. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin. Immunol. 93:152-161. (Pubitemid 29523391)
13. Holt, P. R., S. Katz, and R. Kirshoff. 2005. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig. Dis. Sei. 50:2191-2193. (Pubitemid 41504112)
14. Kundu, P., A. K. Mukhopadhyay, R Patra, A. Banerjee, D. E. Berg, and S. Swarnakar. 2006. Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J. Biol. Chem. 281:34651-34662. (Pubitemid 46036671)
15. Mahady, G. B., S. L. Pendland, G. Yun, and Z. Z. Lu. 2002. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 22:4179-4181. (Pubitemid 36134453)
16. Mukhopadhyay, A. K., D. Kersulyte, J. Y. Jeong, S. Datta, Y. Ito, A. Chowdhury, S. Chowdhury, A. Santra, S. K. Bhattacharya, T. Azuma, G. B. Nair, and D. E. Berg. 2000. Distinctiveness of genotypes of Helicobacter pylori in Kolkata, India. J. Bacteriol. 182:3219-3227. (Pubitemid 30326939)
17. Myllyluoma, E., L. Veijola, T. Ahlroos, S. Tynkkynen, E. Kankuri, H. Vapaatalo, H. Rautelin, and R. Korpela. 2005. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy-a placebo-controlled, double-blind randomized pilot study. Aliment. Pharmacol. Ther. 21:63-72. (Pubitemid 40733493)
18. Nahar, S., A. K. Mukhopadhyay, R. Khan, M. M. Ahmad, S. Datta, S. Chattopadhyay, S. C. Dhar, S. A. Sarker, L. Engstrand, D. E. Berg, G. B. Nair, and M. Rahman. 2004. Antimicrobial susceptibility of Helicobacter pylori strains isolated from Bangladesh. J. QIn. Microbiol. 42:4856-4858. (Pubitemid 39362424)
19. Pardee, A. B., J. Li, C. Crumpacker, and L. Zhang. March 1994. Treatment of human viral infections. U.S. patent US933470, WO9404139.
20. Parish, T., and N. G. Stoker. 2002. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 148:3069-3077. (Pubitemid 35243706)
21. Peitz, U., M. Menegatti, D. Vaira, and P. Malfertheiner. 1998. The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut 43:S66-S69. (Pubitemid 28090608)
22. Rai, D., J. K. Singh, N. Roy, and D. Panda. 2008. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem. J. 410:147-155.
23. Ringman, J. M., S. A. Frautschy, G. M. Cole, D. L. Masterman, and J. L. Cummings. 2005. A potential role of the curry spice curcumin in Alzheimer's disease. Curr. Alzheimer Res. 2:131-136. (Pubitemid 40862872)
24. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Shishodia, S., M. M. Chaturvedi, and B. B. Aggarwal. 2007. Role of curcumin in cancer therapy. Curr. Probl. Cancer 31:243-305. (Pubitemid 47077491)
26. Singh, R., R. Chandra, M. Bose, and P. M. Luthra. 2002. Antibacterial activity of Curcuma longa rhizome extract on pathogenic bacteria. Curr. Sei. 83:737-740. (Pubitemid 135695250)
27. Srinivas, L., V. K. Shalini, and M. Shylaja. 1992. Turmerin: a water soluble antioxidant peptide from turmeric (Curcuma longa). Arch. Biochem. Biophys. 292:617-623.
28. Surh, Y. 1999. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428:305-327. (Pubitemid 29389702)
29. Swarnakar, S., K Ganguly, P. Kundu, A. Banerjee, P. Maity, and A. V. Sharma. 2005. Curcumin regulates expression and activity of matrix metal-loproteinases 9 and 2 during prevention and healing of indomethacin-in-duced gastric ulcer. J. Biol. Chem. 280:9409-9415. (Pubitemid 40409634)
30. Toracchio, S., L. Cellini, E. Di Campli, G. Cappello, M. G. Malatesta, A. Ferri, A. F. Ciccaglione, L. Grossi, and L. Marzio. 2000. Role of antimicro-bial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 14:1639-1643. (Pubitemid 32011737)
31. Westblom, T. U., S. J. Czinn, and J. G. Nedrud (ed.). 1999. Current topics in microbiology and immunology, vol.241. Gastroduodenal disease and Heli-cobacter pylori: pathophysiology, diagnosis and treatment. Springer Verlag, Berlin, Germany. (Pubitemid 30012396)
32. Wong, W. M., Q. Gu, S. K. Lam, F. M. Y. Fung, K. C. Lai, W. H. C. Hu, Y. K. Yee, C. K. Chan, H. H. X. Xia, M. F. Yuen, and B. C. Y. Wong. 2003. Randomized controlled study of rabeprazole, levofloxacin and rifabutin tri-ple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection. Aliment. Pharmacol. Ther. 17:553-560. (Pubitemid 36384814)